Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | EQRX INC | $65,358,000 | – | 13,935,623 | – | 72.57% | – | |
| New | PEAR THERAPEUTICS INC | $16,723,000 | – | 10,859,050 | – | 18.57% | – | |
| INGN | New | INOGEN INC | $7,979,000 | – | 330,000 | – | 8.86% | – |
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | EQRX INC | $65,358,000 | – | 13,935,623 | – | 72.57% | – | |
| New | PEAR THERAPEUTICS INC | $16,723,000 | – | 10,859,050 | – | 18.57% | – | |
| INGN | New | INOGEN INC | $7,979,000 | – | 330,000 | – | 8.86% | – |